Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF (NY: THNR )

21.22 +0.10 (+0.48%)

Official Closing Price Updated: 8:00 PM EDT, Apr 25, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	216
Open	21.09
Bid (Size)	10.58 (1)
Ask (Size)	29.95 (1)
Prev. Close	21.12
Today's Range	21.09 - 21.22
52wk Range	18.56 - 28.19
Shares Outstanding	1,500
Dividend Yield	1.04%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Eli Lilly Stock Soars 34.42% YTD: A $1000 Investment Outpaces Returns From These ETFs Holding Mounjaro-Maker Shares

December 13, 2024

Recently, the company announced a massive $15 billion share buyback plan and a 15% dividend increase.

Via Benzinga

EXCLUSIVE: Weight-Loss Duopoly Breaks As Eli Lilly, Novo Plummet; 'Market Won't Be Dominated By Just 2 Players'

July 18, 2024

Eli Lilly and Novo Nordisk face selloff as new weight-loss drugs threaten dominance. Shares of both companies drop significantly, highlighting need for diversification in this industry.

Via Benzinga

Performance

YTD	-6.21%	-6.21%
1 Month	-2.21%	-2.21%
3 Month	-7.76%	-7.76%
6 Month	-18.16%	-18.16%
1 Year	-16.44%	-16.44%

More News

ETFs Bet High On Weight Loss Drugs, But Industry Observers Question Long-Term Potential

June 07, 2024

Via Benzinga

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.